 |
Recognition of Sepsis-Related Organ Dysfunction
|
Sepsis is diagnosed when there is clinical evidence of organ dysfunction in the setting of probable or confirmed infection. Common signs of sepsis include altered mental status, tachypnea, body temperature > 38.3 degrees Celsius or less than 36 degrees Celsius, and systolic blood pressure less than 100 mm Hg. Laboratory evidence of organ dysfunction includes:
- Lactate >2 mmol/L
- WBC < 4 x109/L or > 10 x109/L
- Creatinine > 2 mg/dL
- INR > 1.5 or APTT > 60 seconds
- Platelet count < 100 x109/L
Sepsis screening tools are designed to help identify sepsis and consist of manual methods or utilization of data in the electronic health record (EHR). Because no screening tool is 100% sensitive for the detection of infection-induced organ dysfunction, clinical judgment and frequent reassessment should be utilized if the diagnosis is uncertain. The 2021 Surviving Sepsis Campaign Guidelines recommends using a performance improvement program for sepsis, which may include screening tools such as the Systemic Inflammatory Response Syndrome (SIRS) criteria ore Sequential (Sepsis-Related) Organ Failure Assessment (SOFA) Score.
Systemic Inflammatory Response Syndrome (SIRS) Criteria
Screening for sepsis using the SIRS criteria includes identifying the presence of two or more of the following symptoms (Evans et al., 2021):
- fever or hypothermia
- tachycardia
- tachypnea
- change in blood leucocyte count
Sequential (Sepsis-Related) Organ Failure Assessment (SOFA) Score (Vincent et al., 1996)
The SOFA score provides clinical measures to identify organ dysfunction; these criteria can identify infected patients most likely to develop sepsis. The baseline score is assumed to be zero in patients without preexisting organ dysfunction and an increase in score of 2 points or more from baseline represents organ dysfunction. Higher scores are associated with increased risk of mortality.
SOFA SCORE |
Score
|
0
|
1
|
2
|
3
|
4
|
Respiration
|
PaO2/FiO2 mm HG (kPa)
|
≥ 400 (53.3)
|
< 400 (53.3)
|
< 300 (40)
|
< 200 (26.7) with respiratory support
|
< 100 (13.3) with respiratory support
|
Coagulation
|
Platelets, x 103/uL
|
≥ 150
|
< 150
|
< 100
|
< 50
|
< 20
|
Liver
|
Bilirubin, mg/dL (umol/L)
|
< 1.2 (20)
|
1.2- 1.9 (20- 32)
|
2.0-5.9 (33- 101)
|
6.0-11.9 (102 -204)
|
> 12.0 (204)
|
Cardiovascular
|
Mean arterial pressure (MAP) and vasopressor therapy (ug/kg/min for at least 1 hour)
|
MAP ≥ 70 mmHg
|
MAP < 70 mmHg
|
Dopamine < 5 or dobutamine (any dose)
|
Dopamine 5.1-15 or epinephrine ≤ 0.1 or norepinephrine ≤ 0.1
|
Dopamine > 15 or epinephrine > 0.1 or norepinephrine > 0.1
|
Central Nervous System
|
Glasgow Coma Scale score
|
15
|
13-14
|
10-12
|
6-9
|
< 6
|
Renal
|
Creatinine, mg/dL (umol/L)
|
< 1.2 (110)
|
1.2-1.9 (110-170)
|
2.0-3.4 (171-299)
|
3.5-4.9 (300-440)
|
> 5.0 (440)
|
Urine output, mL/day
|
|
|
|
< 500
|
< 200
|